Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have reported that a single...

Retinoblastoma, the most common malignant eye tumour in children, has become a new focus of research into the regulatory DNA...

A molecular switch that controls both bone destruction and bone formation may offer a new way to treat postmenopausal osteoporosis,...

The microbiome has become one of the most influential frontiers in modern medicine, but the field still faces a fundamental...

A new review in Experimental & Molecular Medicine examines how autonomous intranasal delivery systems could transform the way medicines reach...

For decades, mammary stem cells have been portrayed as the hidden architects of the breast: rare, self-renewing cells capable of...

Cancer-associated cachexia, the wasting syndrome that erodes muscle, fat and physical resilience in many people with advanced cancer, has long...

WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before...

Anti-angiogenic drugs were expected to starve tumors by cutting off their blood supply. Yet many cancers eventually adapt, finding alternative...

DNA repair has traditionally been viewed as a process centred in the nucleus, where the genome is stored and monitored....